Enzyme vs SoSoValue — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while SoSoValue trades at Rp5,829 (market cap Rp2T, Rp52,87M 24h volume). The key difference: SoSoValue is far larger — about 14910.9× Enzyme's market cap, and SoSoValue's supply is capped (342M / 1B SOSO (35%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and SoSoValue for 10 Days on average.
| MLN | SOSO | |
|---|---|---|
Market Cap | Rp134,13M | Rp2T |
Volume (24h) | Rp104,56M | Rp52,87M |
Circulating Supply | 3,3M MLN | 342M / 1B SOSO (35%) |
Typical Hold Time | 29 Days | 10 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
SoSoValue (SOSO) trades at Rp6,004 with a market cap of Rp2.04 trillion, showing a neutral overall technical signal. The asset is in a consolidation phase near pivot point Rp5,979, with bearish moving averages but oversold short-term RSI. With 35% of max supply in circulation and average hold time of 10 days, token distribution remains gradual. No major protocol updates or ecosystem news were identified recently.
Outlook: Neutral with caution due to mixed technical signals and limited fundamental catalysts. Opportunity lies in potential bounce from oversold RSI levels, while risks include low liquidity and absence of recent development momentum. Investors should monitor volume breakouts above resistance levels for directional confirmation.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →SoSoValue is an AI-driven investment and research platform that merges the efficiency of centralized finance (CeFi) with the transparency of decentralized finance (DeFi), tackling issues such as information overload and cross-chain asset management in the cryptocurrency market.
Read more on SOSO →